The DC Circuit Court of Appeals affirms a lower court decision recognizing FDAs authority to place homeopathic drugs on its import alert listing after...
FDAs fiscal year 2022 budget request seeks an 8% ($477 million) boost for agency activities.
Federal Register notice: FDA withdraws a notice by the previous administration that would have ended the agencys unapproved drugs initiative.
Federal Register notice: FDA makes available a draft guidance entitled Procedures for Handling Post-Approval Studies Imposed by Premarket Approval App...
Federal Register notice: FDA makes available a draft guidance entitled Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmet...
FDA approves a Foresee Pharmaceuticals NDA for Camcevi (leuprolide mesylate) 42 mg for treating advanced prostate cancer.
The Federal Trade Commission asks the Supreme Court not to hear AbbVies appeal of lower court decisions holding that it engaged in sham litigation to ...
The Justice Department says a Georgia man has been sentenced to five years probation for conspiracy to distribute unapproved drugs and unlawful smuggl...